(2R,3R)-2-{[(tert-Butoxy)carbonyl]amino}-3-hydroxybutanoic acid

CAS : 85979-33-5

Ref. 3D-KDA97933

Informations sur le produit

• Nom: (2R,3R)-2-{[(tert-Butoxy)carbonyl]amino}-3-hydroxybutanoic acid

Description

Pf-06305591 is a benzimidazole blocker that is being developed for the treatment of epilepsy. Pf-06305591 blocks sodium channels in the central nervous system, which are involved in neuronal excitability and seizure generation. This drug has been shown to be safe and well tolerated in preclinical studies. Pf-06305591 was discovered by optimizing chemical structures of phenylimidazole blockers, which have been shown to have efficacy against seizures but with a high incidence of adverse effects. Pf-06305591 has been shown to be effective at a dose that is well tolerated, with an optimized safety profile that can be individualized according to the patient's needs.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 219.23 g/mol
• Formule: C₉H₁₇NO₅
• Degré de pureté: Min. 95%